Clinical trials of adenoviruses in brain tumors: a review of Ad-p53 and oncolytic adenoviruses.
about
Chloroquine activates the p53 pathway and induces apoptosis in human glioma cellsThe status of gene therapy for brain tumorsNovel delivery strategies for glioblastomaReal-time PCR in clinical microbiology: applications for routine laboratory testing.[Transcriptional inhibition of human papilloma virus in cervical carcinoma cells reactivates functions of the tumor suppressor p53].Targeting human glioblastoma cells: comparison of nine viruses with oncolytic potential.Gene therapy and targeted toxins for glioma.Gene therapy for malignant glioma.Targeted therapy for brain tumours.Chaperone proteins and brain tumors: potential targets and possible therapeutics.Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 4: p53 signaling pathway.Negative regulation-resistant p53 variant enhances oncolytic adenoviral gene therapy.Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 5: apoptosis and cell cycle.Molecular strategies for the treatment of malignant glioma--genes, viruses, and vaccines.Adenoviral virotherapy for malignant brain tumorsTherapeutic nanomedicine for brain cancer.Gene therapy for high-grade glioma: current approaches and future directions.Stem cells as delivery vehicles for oncolytic adenoviral virotherapy.Adenoviral Vectors Armed with Cell Fusion-Inducing Proteins as Anti-Cancer Agents.Oncolytic-adenovirus-expressed RNA interference for cancer therapy.Therapeutic strategies for head and neck cancer based on p53 status.Biodegradable brain-penetrating DNA nanocomplexes and their use to treat malignant brain tumors.Evolving lessons on nanomaterial-coated viral vectors for local and systemic gene therapy.A Lentiviral Vector Expressing Desired Gene Only in Transduced Cells: An Approach for Suicide Gene Therapy.A novel double-enhanced suicide gene therapy in a colon cancer cell line mediated by gef and apoptin.RNA interference-mediated knockdown of p21(WAF1) enhances anti-tumor cell activity of oncolytic adenoviruses.Syncytia formation affects the yield and cytotoxicity of an adenovirus expressing a fusogenic glycoprotein at a late stage of replication.Silencing of stathmin induces tumor-suppressor function in breast cancer cell lines harboring mutant p53.Gene- and viral-based therapies for brain tumorsMiRNA-mediated tumor specific delivery of TRAIL reduced glioma growth.Employment of liver tissue slice analysis to assay hepatotoxicity linked to replicative and nonreplicative adenoviral agents.An ex vivo loop system models the toxicity and efficacy of PEGylated and unmodified adenovirus serotype 5 in whole human blood.Viruses in the treatment of malignant glioma.Gene therapy and targeted toxins for glioma
P2860
Q24607826-FA795900-874F-46E7-9494-5443A36F0139Q24651009-73D58DE6-3428-4CCD-963E-C8418D99B0FBQ27006099-234E6371-5103-4620-B06B-23FD3AE853F0Q27472851-E60AC458-7861-45FE-95A0-EA3C83023B11Q33293557-5659D4E2-F6C0-4816-ADE6-FAD0F5E30B4CQ33780536-80975A69-9C3F-496C-BBD6-1B88056F24C1Q35118933-FD199EB4-CD8B-4747-B829-19F7D12B943BQ35673628-F7133B38-2755-4299-A633-938A271E4434Q35790376-084E01F7-CEF1-41B3-8BF2-A070D65E59C0Q35800492-391013A9-1DBA-41A7-8205-15A9E675B9ECQ36066191-089C6DFF-D2B2-47C1-BAA5-9887E249C200Q36084467-273BA02F-3AD0-49F5-B10B-13EE74D8041DQ36118431-3A7B4331-D945-45EF-8EF3-5D7A52172EE3Q37079854-FEECF8DB-89EA-4F24-9BA3-5749F6FB7856Q37223846-7EF91516-1B35-49F7-8A76-51A8C91EEFC3Q37338427-BAF17D8B-8F9F-4A50-8A10-6A140740AD35Q37406685-217DCCE9-F5B1-46C4-A156-F91F206B4C26Q37466041-7228DAEE-A3BF-44DE-91DC-5568000015A8Q37628219-DFA45620-1407-4FE3-9C85-C327A9B18748Q37777745-4389B14A-E698-4DD1-B4D1-147AED4EA7AEQ38042630-796434F1-83FC-4D29-A5B8-BED61D230D20Q38685603-383AB3B7-50A5-4921-B75A-0303D076B949Q38848060-25581FD2-F542-4529-A9A2-EFCED6A4358BQ38870602-579E46C3-222F-4565-9DEF-3E76152E8D93Q39114380-3BECACC3-2A9A-4F89-8845-4D09BD43E0B8Q39858149-3ACC3215-D8C8-422F-B6D4-8701AB0A45ADQ39977445-6734492F-6CA2-47DC-B32C-A0E891E21F2DQ40243704-3FFF0F2F-14C5-4A39-BCC0-137B00FBA846Q42135456-A2C72E9E-5683-4A42-8784-BEC77E7AB722Q44522644-C4024F1A-08A4-458A-B0DD-AD61BEB91FD4Q45855170-B5BFF7F3-C493-4478-B7B2-FA5A72D7BAF2Q45857526-D364526F-19E0-4188-A63F-8370E3A01E57Q48209572-811ECD9B-EEF9-4F23-BB08-235770145BBCQ57006162-E2561FD1-DA3B-40E2-AAF7-DC1B5C0D9D76
P2860
Clinical trials of adenoviruses in brain tumors: a review of Ad-p53 and oncolytic adenoviruses.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Clinical trials of adenoviruse ...... 53 and oncolytic adenoviruses.
@ast
Clinical trials of adenoviruse ...... 53 and oncolytic adenoviruses.
@en
type
label
Clinical trials of adenoviruse ...... 53 and oncolytic adenoviruses.
@ast
Clinical trials of adenoviruse ...... 53 and oncolytic adenoviruses.
@en
prefLabel
Clinical trials of adenoviruse ...... 53 and oncolytic adenoviruses.
@ast
Clinical trials of adenoviruse ...... 53 and oncolytic adenoviruses.
@en
P1476
Clinical trials of adenoviruse ...... 53 and oncolytic adenoviruses.
@en
P2093
Frederick F Lang
Giacomo G Vecil
P304
P356
10.1023/B:NEON.0000003653.45635.32
P577
2003-12-01T00:00:00Z
P6179
1029965524